Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on October 18, 2007

Cardiovascular Research, doi:10.1093/cvr/cvm039
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
77/2/416    most recent
cvm039v3
cvm039v2
cvm039v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Javadov, S.
Right arrow Articles by Karmazyn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javadov, S.
Right arrow Articles by Karmazyn, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

NHE-1 inhibition-induced cardioprotection against ischemia/reperfusion is associated with attenuation of the mitochondrial permeability transition

NHE-1 inhibition attenuates mitochondrial permeability transition in IR

Sabzali Javadov, Angel Choi, Venkatesh Rajapurohitam, Asad Zeidan, Alexei G. Basnakian1 and Morris Karmazyn*

Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada N6A 5C1
1 Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA

* Address for correspondence: Dr M Karmazyn Department of Physiology and Pharmacology Schulich School of Medicine and Dentistry University of Western Ontario London, Ontario N6A 5C1 Canada Tel: (519) 661-3872 Fax: (519) 661-3827 E-mail: morris.karmazyn{at}schulich.uwo.ca

Aims: The possible contribution of the cardiac mitochondrial permeability transition pore (PTP) towards the cardioprotective effects of Na+-H+ exchanger-1 (NHE-1) inhibition was studied in hearts subjected to ischemia/reperfusion (IR).

Methods: Langendorff-perfused rat hearts were subjected to 40 min of global ischemia and 60 min of reperfusion in the presence or absence of the NHE-1 specific inhibitor AVE-4890 (AVE, 5µM). Mitochondrial PTP opening was determined in the intact heart using 2-deoxy-[3H]-glucose entrapment and in isolated mitochondria by monitoring the decrease of the calcium-induced light scattering. Mitochondrial respiration was measured with a Clark-type oxygen electrode whereas release of apoptosis-inducing factor (AIF) and endonuclease G (EndoG) and levels of cleaved poly (ADP-ribose) polymerase (PARP) were analyzed by Western blotting.

Results: IR induced mitochondrial PTP opening which was inhibited by 28% (P<0.05) with AVE treatment. Mitochondria isolated from AVE-treated hearts demonstrated significantly less calcium-induced swelling and higher substrate oxidation at complex I and II as well as cytochrome c oxidase and citrate synthase activity. AVE treatment also suppressed IR-induced release of AIF and EndoG from mitochondria, prevented the IR-induced rise in cleaved PARP levels, and was associated with significantly enhanced postischemic recovery of left ventricular developed pressure and a significant decrease in lactate dehydrogenase release. AVE did not affect PTP opening directly in isolated mitochondria.

Conclusions: The beneficial effect of NHE-1 inhibition in hearts subjected to IR is associated with attenuation of mitochondrial PTP opening and apoptosis and the resultant mitochondrial dysfunction. The effect of AVE on PTP opening most likely is indirect as pore opening was not affected by direct administration of AVE to mitochondrial suspensions.

KEYWORDS heart; ischemia; reperfusion; mitochondria; sodium-hydrogen exchanger; apoptosis


Time for primary review: 23 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Javadov, M. Karmazyn, and N. Escobales
Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases
J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 670 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. D. Garciarena, C. I. Caldiz, M. V. Correa, G. R. Schinella, S. M. Mosca, G. E. Chiappe de Cingolani, H. E. Cingolani, and I. L. Ennis
Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action
J Appl Physiol, December 1, 2008; 105(6): 1706 - 1713.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Garcia-Dorado, H. M. Piper, and D. A. Eisner
Sarcoplasmic reticulum and mitochondria in cardiac pathophysiology
Cardiovasc Res, January 15, 2008; 77(2): 231 - 233.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.